Is Thermo Fisher (TMO) a Safe Investment Pick?

Stewart Asset Management, an investment management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here. In the second quarter of 2022, the Flagship portfolio declined 20.77%, net of fees. According to the fund, retrenchments are an ugly stalker in all markets, but, importantly, they create opportunities. Stewart Asset Management believes that a strong case can be made for their clients’ capital at least doubling over the next half-decade. Go over the fund’s top 5 positions to have a glimpse of its finest picks for 2022.

In its Q2 2022 investor letter, Stewart Asset Management mentioned Thermo Fisher Scientific Inc. (NYSE:TMO) and explained its insights for the company. Founded in 1956, Thermo Fisher Scientific Inc. (NYSE:TMO) is a Waltham, Massachusetts-based scientific instrumentation, reagents and consumables, and software services supplier with a $224.4 billion market capitalization. Thermo Fisher Scientific Inc. (NYSE:TMO) delivered a -14.08% return since the beginning of the year, while its 12-month returns are up by 8.11%. The stock closed at $573.27 per share on July 26, 2022. 

Here is what Stewart Asset Management has to say about Thermo Fisher Scientific Inc. (NYSE:TMO) in its Q2 2022 investor letter:

“Recently we initiated two new investments. One in Thermo Fischer Scientific (NYSE:TMO), a supplier to the life sciences industry. We have followed the company for many years and the recent downturn in share price gave us a good entry price at which to invest. Thermo has had strong earnings growth for many years and is led by a superb team. The company’s recent acquisitions make it a full-service supplier to the biopharma and biotech industries.”

Copyright: nexusplexus / 123RF Stock Photo

Our calculations show that Thermo Fisher Scientific Inc. (NYSE:TMO) ranks 17th on our list of the 30 Most Popular Stocks Among Hedge Funds. Thermo Fisher Scientific Inc. (NYSE:TMO) was in 101 hedge fund portfolios at the end of the second quarter of 2022, compared to 95 funds in the previous quarter. Thermo Fisher Scientific Inc. (NYSE:TMO) delivered a 11.00% return in the past 3 months.

In April 2022, we also shared another hedge fund’s views on Thermo Fisher Scientific Inc. (NYSE:TMO) in another article. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters 2022 Q1 page.

Disclosure: None. This article is originally published at Insider Monkey.